These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9726835)

  • 1. Role of the target organ in determining susceptibility to experimental autoimmune myasthenia gravis.
    Hoedemaekers A; Bessereau JL; Graus Y; Guyon T; Changeux JP; Berrih-Aknin S; van Breda Vriesman P; De Baets MH
    J Neuroimmunol; 1998 Aug; 89(1-2):131-41. PubMed ID: 9726835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related resistance to experimental autoimmune myasthenia gravis in rats.
    Graus YM; Verschuuren JJ; Spaans F; Jennekens F; van Breda Vriesman PJ; De Baets MH
    J Immunol; 1993 May; 150(9):4093-103. PubMed ID: 8386206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.
    Barchan D; Asher O; Tzartos SJ; Fuchs S; Souroujon MC
    Eur J Immunol; 1998 Feb; 28(2):616-24. PubMed ID: 9521072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the rate of acetylcholine receptor synthesis on the severity of experimental autoimmune myasthenia gravis.
    De Baets MH; Verschuuren J; Daha MR; van Breda Vriesman PJ
    Immunol Res; 1988; 7(3):200-11. PubMed ID: 3264006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential susceptibility of young and old rat neuromuscular junctions to antibody-mediated AChR degradation in experimental autoimmune myasthenia gravis.
    Hoedemaekers A; Bessereau JL; Graus Y; Guyon T; Changeux JP; Berrih-Aknin S; Van Breda Vriesman P; De Baets M
    Ann N Y Acad Sci; 1998 May; 841():550-4. PubMed ID: 9668293
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
    Losen M; Stassen MH; Martínez-Martínez P; Machiels BM; Duimel H; Frederik P; Veldman H; Wokke JH; Spaans F; Vincent A; De Baets MH
    Brain; 2005 Oct; 128(Pt 10):2327-37. PubMed ID: 16150851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related susceptibility to experimental autoimmune myasthenia gravis: immunological and electrophysiological aspects.
    Hoedemaekers AC; Verschuuren JJ; Spaans F; Graus YF; Riemersma S; van Breda Vriesman PJ; De Baets MH
    Muscle Nerve; 1997 Sep; 20(9):1091-101. PubMed ID: 9270663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased gene expression of acetylcholine receptor and myogenic factors in passively transferred experimental autoimmune myasthenia gravis.
    Asher O; Kues WA; Witzemann V; Tzartos SJ; Fuchs S; Souroujon MC
    J Immunol; 1993 Dec; 151(11):6442-50. PubMed ID: 8245477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.
    Araga S; Galin FS; Kishimoto M; Adachi A; Blalock JB
    J Immunol; 1996 Jul; 157(1):386-92. PubMed ID: 8683141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor.
    Tzartos S; Hochschwender S; Vasquez P; Lindstrom J
    J Neuroimmunol; 1987 Jun; 15(2):185-94. PubMed ID: 3495549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of passively transferred experimental autoimmune myasthenia gravis using papain.
    Poulas K; Tsouloufis T; Tzartos SJ
    Clin Exp Immunol; 2000 May; 120(2):363-8. PubMed ID: 10792389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.
    Lindstrom JM; Einarson BL; Lennon VA; Seybold ME
    J Exp Med; 1976 Sep; 144(3):726-38. PubMed ID: 182896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor.
    Loutrari H; Kokla A; Tzartos SJ
    Eur J Immunol; 1992 Sep; 22(9):2449-52. PubMed ID: 1516631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage infiltration at the neuromuscular junction does not contribute to AChR loss and age-related resistance to EAMG.
    Hoedemaekers A; Graus Y; Beijleveld L; van Breda Vriesman P; De Baets M
    J Neuroimmunol; 1997 May; 75(1-2):147-55. PubMed ID: 9143248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of acetylcholine receptor alpha-subunit mRNA in experimental autoimmune myasthenia gravis.
    Asher O; Neumann D; Fuchs S
    FEBS Lett; 1988 Jun; 233(2):277-81. PubMed ID: 3260196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
    Mihovilovic M; Donnelly-Roberts D; Richman DP; Martinez-Carrion M
    J Immunol; 1994 Jun; 152(12):5997-6002. PubMed ID: 8207224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
    Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
    Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell autoimmunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Qiao J; Olsson T; Huang WX
    J Neuroimmunol; 1993 Jun; 45(1-2):103-12. PubMed ID: 8331155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats. Association with decreased amounts of in situ acetylcholine receptor-antibody complexes.
    Biesecker G; Koffler D
    J Immunol; 1988 May; 140(10):3406-10. PubMed ID: 3258882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.